Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effects of Sirolimus in Patients With Dilated Cardiomyopathy Infected With Kaposi Sarcoma-associated Virus

NCT06236022 is registered in ClinicalTrials.gov with Tongji Hospital as lead sponsor.

NCT NCT06236022
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06236022 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effects of Sirolimus in Patients With Dilated Cardiomyopathy Infected With Kaposi Sarcoma-associated Virus
Lead sponsor
Tongji Hospital
Phase
Phase 4
Overall status
Recruiting
Start date
January 1, 2024
Completion date
December 31, 2028
Enrollment
276 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dilated cardiomyopathy, kaposi's sarcoma-associated herpesvirus infection